Table 4.
MDS-UPDRS subscales.
Comparison (adjusted for presinging baseline) | Part 1 | Part 2 | Part 3 | Part 4 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Δ | P value | R 2 | Δ | P value | R 2 | Δ | P value | R 2 | Δ | P value | R 2 | ||
Overall cohort (weeks compared) | 12–BL | −0.4 | 0.839 | 0.006 | −3.6 | 0.058 | 0.168 | 0.7 | 0.748 | 0.018 | −2.7 | 0.109 | 0.358 |
24–12 | −1.4 | 0.370 | 0.354 | −0.3 | 0.888 | 0.011 | 3.0 | 0.435 | 0.029 | −1.4 | 0.275 | 0.142 | |
24–BL | −0.7 | 0.676 | 0.065 | −3.3 | 0.118 | 0.096 | 3.7 | 0.285 | 0.11 | −2.4 | 0.221 | 0.246 | |
Singing 1st vs. singing 2nd | Δ from start to end interventions | −1.5 | 0.404 | 0.281 | −3.6 | 0.051 | 0.171 | −6.9 | 0.110 | 0.164 | −1.0 | 0.427 | 0.264 |
Δ final visit (week 30) vs. end interventions (week 24) | −0.7 | 0.620 | 0.018 | −1.9 | 0.133 | 0.105 | −3.9 | 0.350 | 0.189 | −1.2 | 0.303 | 0.106 |